Latest Comments on A. Reza Saadat's Articles

1. A. Reza Saadat on Vertex's Telaprevir May Become a Multi-Billion Dollar Drug: Dear TwinStridesForCF: I hope you read this. I know your... more »
2. turd furgeson on Amylin, Lilly: Another Case of a Panic Driven Sell-Off: 10-20% higher? How about 80% lower. Nice call. more »
3. turd furgeson on Amylin, Lilly: Another Case of a Panic Driven Sell-Off: Hopefully you didn't follow your own advice. more »
4. PeteK on Celgene Becomes a Bargain Once Again: I won't buy drug companies untill there are new laws to prevent... more »
5. Shiv139 on Celgene Becomes a Bargain Once Again: I could not agree more. Personally, I feel health-care offers... more »
6. crimfunk on Celgene Becomes a Bargain Once Again: and this WASHINGTON (Dow Jones)--The Food and Drug... more »
7. theblueamerican on Amylin, Lilly: Another Case of a Panic Driven Sell-Off: I agree. Everything that I have read about Byetta tells me that... more »
8. User 238059 on Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity: Yes, looks like back into the teens is a reality. more »
9. I Buy Elan on Biogen-Idec, Elan: Panic Selling Creates Interesting Opportunity: I am a trader and receive monthly infusions of Tysabri. Traders... more »
10. turd furgeson on Amylin Has Yet to Crack Tough Diabetes Market: Byetta is not going approved for weight loss any time soon in... more »
11. odyd12 on AMAG's Iron Replacement Therapy: Great Potential, Problematic Trial: Ferumoxytol is awaiting decision in chronic kidney disease not... more »
12. hoopdreamerz@yahoo.com on AMAG's Iron Replacement Therapy: Great Potential, Problematic Trial: Reza, that's just one amag phase III trial of many. They didn't... more »
13. KteacherinCal on Amylin Has Yet to Crack Tough Diabetes Market: I figure now is a time to buy... with the FDA possibly approving... more »
14. turd furgeson on Amylin Has Yet to Crack Tough Diabetes Market: The only way for AMLN to succeed is a buyout, which should happen.... more »
15. jimmy Turano on Amylin Has Yet to Crack Tough Diabetes Market: Dear Mr. Saadat,Your precise frank report on diabetes and amln is... more »